Food allergy diagnostic company Reacta Biotech secures GBP2.9m investment
A business that is aiming to transform the food allergy diagnostics market has secured GBP2.9 million investment in a funding round led by Praetura Ventures with follow-on equity investment from the Development Bank of Wales. Reacta Biotech (Reacta), which is based in Deeside, North Wales, produces clinical diagnostics kits